Management of Severe Allergic Rhinitis in Pregnancy
Intranasal corticosteroids are the first-line treatment for severe allergic rhinitis with ocular symptoms during pregnancy due to their superior safety and efficacy profile. 1
First-Line Treatment Options
- Intranasal corticosteroids (INCs) are the most effective therapy for allergic rhinitis and have minimal systemic absorption when used at recommended doses 1, 2
- Budesonide is the preferred intranasal corticosteroid during pregnancy (Pregnancy Category B) with the most established safety data 3, 4
- Other intranasal corticosteroids such as fluticasone and mometasone are also considered safe based on their limited systemic absorption 1, 4
- Second-generation antihistamines can be used, with loratadine and cetirizine (both FDA Pregnancy Category B) having the most established safety data during pregnancy 3, 5
Second-Line Treatment Options
- Sodium cromolyn nasal spray is safe during pregnancy (Pregnancy Category B) but requires frequent dosing (4 times daily) which limits patient acceptance 1, 2
- Montelukast (Pregnancy Category B) may be considered if there was a uniquely favorable pre-pregnancy response, but has limited data in pregnancy 1, 2
- First-generation antihistamines like chlorphenamine have extensive safety data in pregnancy but cause sedation 6, 4
Medications to Use with Caution or Avoid
- Fexofenadine (Pregnancy Category C) has limited human pregnancy data, although animal studies have not shown teratogenic effects 7, 4
- Oral decongestants should be avoided, especially during the first trimester, due to potential associations with congenital malformations 1, 3
- If a decongestant is absolutely necessary, topical decongestants may be used short-term (up to 7 days) with caution 1, 8
- Combining decongestants with acetaminophen or salicylates may increase risk of malformations 1
Treatment Algorithm for Severe Allergic Rhinitis in Pregnancy
- Start with intranasal corticosteroids (preferably budesonide) as first-line therapy 1, 3
- Add second-generation antihistamine (loratadine or cetirizine) if additional symptom control is needed 3, 5
- For ocular symptoms, consider ophthalmic antihistamines (pheniramine has safety data in pregnancy) 1, 6
- For patients not responding to the above, consider sodium cromolyn nasal spray as an adjunct therapy 1, 2
- Reserve montelukast for patients with a documented favorable pre-pregnancy response 1, 2
Important Clinical Considerations
- The first trimester carries the highest risk for medication-induced teratogenicity, so benefit-risk assessment is crucial 2, 3
- Untreated severe allergic rhinitis can negatively affect maternal quality of life and potentially impact fetal outcomes through sleep disturbance and reduced oral intake 9, 4
- Misconceptions about medication safety during pregnancy can lead to suboptimal treatment that may be more harmful than appropriate medication use 8, 4
- Patient education about the safety of recommended medications is essential to ensure adherence and optimal symptom control 6, 5
Common Pitfalls to Avoid
- Assuming all antihistamines have equivalent safety profiles during pregnancy 2, 3
- Prolonged use of topical decongestants leading to rhinitis medicamentosa 8, 5
- Discontinuing previously effective therapy without adequate replacement, leading to poor symptom control 9, 4
- Overestimating risks of well-studied medications while underestimating the impact of untreated symptoms on maternal and fetal wellbeing 6, 4